- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0018510

About Enaltec Labs Private Limited
Data last updated:
Enaltec Labs Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of La Renon Healthcare Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21001MH2006PTC160020. Its GSTIN is 27AABCE5821H1ZS (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹112 Cr and a paid-up capital of ₹93.5 Cr. It is led by directors including Anand Prafulchandra Shah (Managing Director) and Bhavesh Bansidhar Pujara.
Its last annual general meeting (AGM) was held on 20 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Sector 19, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹169.73 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹58.54 Cr (net margin -34.5%) and EBITDA of -₹36.35 Cr (EBITDA margin -21.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
The company has about 286 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Enaltec Labs. As per MCA filings, the company has open charges of ₹76.2 Cr and satisfied charges of ₹320.53 Cr on record. Court records list 26 cases involving the company, including 5 filed by the company and 21 filed against it; 2 cases are pending. The company has 14 deals on record (12 funding rounds, 2 secondary share transfers), with disclosed funding of ₹271.98 Cr; the latest was in January 2022. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is GMFC Labs Private Limited with revenue of ₹179.23 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2024, listing 1,415 overdue payments to 146 micro and small suppliers.
Enaltec Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0018510). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enaltec.com.
Company details
CIN history
Enaltec Labs has one previous CIN (Corporate Identification Number): U73100MH2006PTC160020. The current CIN is U21001MH2006PTC160020, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21001MH2006PTC160020 | Current |
| U73100MH2006PTC160020 | Previous |
Recognitions & Rankings of Enaltec Labs
Contact details
Enaltec Labs Private Limited's registered office is in Thane, Maharashtra.
- Social Media
- Registered Address401 4th Floor Kesar Solitaire, Plot No 5 Sector 19 Sanpada Navi Mumbai, Thane, Maharashtra, India – 400705
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Enaltec Labs operates one associated brand: Enaltec Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Non-oncology APIs are developed and manufactured by Enaltec Labs. | enaltec.com |
Business activity
The main business activity of Enaltec Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Enaltec Labs Private Limited, buy the company report.
Financials of Enaltec Labs Private Limited
FY 2026 filings availableEnaltec Labs Private Limited reported revenue of ₹169.73 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 11% growth in the latest year. EBITDA fell 709% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹36.35 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹58.54 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -21.4% | ||||
| Net Profit Margin | -34.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enaltec Labs Private Limited, buy the company report.
Board of directors of Enaltec Labs Private Limited
Enaltec Labs has 3 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavesh Bansidhar Pujara Also directs: Hetero Plasma Sciences Private Limited | Nominee Director | 30 Dec 2025 | 0 Years 9 Months | Current |
| Amish Vyas Pravinchandra Also directs: Ai4pharma Tech Limited | Nominee Director | 20 Jun 2025 | 1 Years 4 Months | Current |
| Anand Prafulchandra Shah | Managing Director | 11 May 2007 | 19 Years 5 Months | Current |
Peer comparison
Enaltec Labs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GMFC Labs Private Limited | ₹179.23 Cr (FY 2025) | 106.0% | Hyderabad, Telangana, India | |||
| Chandak Laboratories Private Limited | ₹178.82 Cr (FY 2024) | -26.0% | Hyderabad, Telangana, India | |||
| Mahima Lifesciences Private Limited | ₹177.98 Cr (FY 2025) | -18.0% | Delhi, India | |||
| Infinity Laboratories Private Limited | ₹176.27 Cr (FY 2025) | -26.0% | Derabassi, Punjab, India | |||
| Elppe Chemicals Private Limited | ₹173.94 Cr (FY 2024) | 8.0% | Raigad, Maharashtra, India | |||
| Enaltec Labs Private Limitedthis company | ₹169.73 Cr (FY 2025) | -₹58.54 Cr | -34.5% | 11.0% | Thane, Maharashtra, India | |
| Mac-Chem Products (India) Private Limited | ₹167.51 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Vamsi Labs Limited | ₹167.4 Cr (FY 2025) | 28.0% | North Solapur, Maharashtra, India | |||
| Srini Pharmaceuticals Private Limited | ₹165.56 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India | |||
| Chromo Laboratories India Private Limited | ₹164.91 Cr (FY 2025) | -6.0% | Patancheru, Telangana, India |
To see the full peer comparison of Enaltec Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2025 | 101157866 | Others | ₹60 Cr | Open | |
| 04 Sep 2025 | 101158294 | Others | ₹15 Cr | Open | |
| 29 Sep 2023 | 100799986 | Others | ₹1.2 Cr | Open | |
| 30 Dec 2020 | 100407081 | Axis Bank Limited | ₹4.93 Cr | Satisfied | |
| 20 May 2019 | 100267190 | Others | ₹17.07 Cr | Satisfied |
To see the full charge records of Enaltec Labs Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Enaltec Labs Private Limited has 14 deals on record (12 funding rounds, 2 secondary share transfers), with disclosed funding of ₹271.98 Cr; the latest was in January 2022.
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2022 | Funding round | ₹55 Cr | Investors: La Renon Healthcare Private Limited , InvAscent |
| Feb 2020 | Funding round | ₹10 Cr | Investors: an individual |
| Dec 2008 | Funding round | ₹81.6 Lakh | Investors: Pharma Serv Ventures Private Limited |
| Jul 2007 | Funding round | ₹3.99 Cr | Investors: Scitech Limited, Pharma Serv Ventures Private Limited , Medtech Limited |
| Sep 2006 | Secondary share transfer | Undisclosed | Buyer: Pharma Serv Ventures Private Limited Seller: 2 individuals |
To see the full deal history of Enaltec Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Enaltec Labs Private Limited has 26 court cases on record: 5 filed by Enaltec Labs, 21 filed against it. 2 cases are pending and 24 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 19 | 2 |
| High courts | 3 | 0 | 0 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Ms Dewberry Enterprise Pvt Ltd and 1 other | Pending |
| District court, Thane, Maharashtra | Court case (Spl .Dkst) | Filed against the company by M/S Aalidhra Pharma Chem Pvt. Ltd. Nikhil Kachhadia | Disposed |
| District court, Hyderabad Central, Telangana | Court case (STC - NI) | Filed against the company by Innovare Labs Private Limited Rep. by Mr. Subrat Sahoo | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by Hy-Gro Chemicals Pharmtek Pvt. Ltd | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by Innovare Labs Private Limited | Disposed |
To see the full case history of Enaltec Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Enaltec Labs Private Limited was last rated by Crisil on 21 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 21 Oct 2020 |
To see the full credit ratings and regulatory alerts of Enaltec Labs Private Limited, buy the company report.
MSME payment delays
Enaltec Labs Private Limited has 15 MSME Form 1 returns on record between 2019 and 2024, listing 1,415 overdue payments to 146 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 146)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nikita Chemical Industries CRS | |||
| an individual supplier | |||
| Av Processors Private Limited | |||
| an individual supplier | |||
| Sugen Life Sciences Private Limited |
To see the full MSME payment records of Enaltec Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Enaltec Labs has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE5821H1ZS | Maharashtra | Active | 01 Jul 2017 |
| 23AABCE5821H1Z0 | Madhya Pradesh | Active | 01 Jul 2017 |
| 29AABCE5821H1ZO | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Enaltec Labs Private Limited, buy the company report.
Recent activity
Enaltec Labs Private Limited has 19 board changes on record since 2007: 3 appointments and 16 cessations. The latest: Bhavesh Bansidhar Pujara was appointed as Nominee Director on 30 Dec 2025.
47 earlier events are in the company report.
Frequently asked questions
Enaltec Labs is an active private limited company based in Thane, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 February 2006 (20+ years old) and is registered under CIN U21001MH2006PTC160020.
Enaltec Labs has 3 current directors:
- Anand Prafulchandra Shah - Managing Director
- Bhavesh Bansidhar Pujara - Nominee Director
- Amish Vyas Pravinchandra - Nominee Director
The latest financial statements of Enaltec Labs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 20 July 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Enaltec Labs is 27AABCE5821H1ZS, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 23AABCE5821H1Z0 (Madhya Pradesh), 29AABCE5821H1ZO (Karnataka).
The CIN (Corporate Identification Number) of Enaltec Labs is U21001MH2006PTC160020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enaltec Labs has 26 court cases on record: 5 filed by the company and 21 filed against it. 2 are pending. Most are in the district courts.
Enaltec Labs was incorporated on 24 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Enaltec Labs has 14 deals on record (12 funding rounds, 2 secondary share transfers), with disclosed funding of ₹271.98 Cr; the latest was in January 2022.
The peers of Enaltec Labs by revenue are GMFC Labs Private Limited, Chandak Laboratories Private Limited, Mahima Lifesciences Private Limited, Infinity Laboratories Private Limited, Elppe Chemicals Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhavesh Bansidhar Pujara was appointed as Nominee Director on 30 Dec 2025. Amish Vyas Pravinchandra was appointed as Nominee Director on 20 Jun 2025. Sumit Gupta ceased to be Nominee Director on 26 Oct 2024. Enaltec Labs has 19 board changes on record in total.
Yes, Enaltec Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0018510).
Enaltec Labs has 15 MSME Form 1 returns on record between 2019 and 2024, listing 1,415 overdue payments to 146 micro and small suppliers. The latest return was filed on 01 May 2024.